Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M403Revenue $M0.2Net Margin (%)--Altman Z-Score-14.5
Enterprise Value $M565EPS $-0.3Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score2.1Pre-tax Margin (%)--Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %-20.0Quick Ratio0.2Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %-26.3Current Ratio0.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-36.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M409ROIC % (ttm)-479.3Gross Margin Increase y-yN

Gurus Latest Trades with MNKD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
MNKDFirst Eagle Investment 2013-03-31 Sold Out -0.01%$2.31 - $3.56
$ 0.98-64%Sold Out0
MNKDFirst Eagle Investment 2012-12-31 Buy 0.01%$1.85 - $2.83
$ 0.98-55%New holding800,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MNKD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

MNKD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Martens JuergenCorporate VP and COO 2015-05-21Buy20,000$4.57-78.56view
Edstrom HakanPresident & CEO 2015-04-24Sell73,460$4.83-79.71view
Edstrom HakanPresident & CEO 2015-03-27Sell73,460$5.21-81.19view
Martens JuergenCorporate VP and COO 2015-03-02Sell121,333$6.54-85.02view
Thomson DavidVP & General Counsel 2015-02-19Sell68,662$7.19-86.37view
Edstrom HakanPresident & CEO 2015-02-10Sell73,460$7.75-87.35view
Palumbo DianeVice President, Human Resource 2015-02-05Sell149,833$6.95-85.9view
Thomson DavidVP & General Counsel 2015-02-05Sell80,000$7-86view
Edstrom HakanPresident & CEO 2015-01-30Sell73,460$6.34-84.54view
Palumbo DianeVice President, Human Resource 2015-01-05Sell188,999$5.95-83.53view

Press Releases about MNKD :

Quarterly/Annual Reports about MNKD:

    News about MNKD:

    Articles On GuruFocus.com
    Why MannKind Could Be a Value Trap Jan 04 2016 
    MannKind Corporation Disappoints with Afrezza Sales; Analysts Lower Expectations May 11 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 
    Analysts Weigh in on MannKind Following Q4 Results Feb 27 2015 
    What to Watch for: November 3-7 Nov 04 2014 
    Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
    Evaluating MannKind (MNKD) & Sanofi (SNY) Agreement for Afrezza Aug 15 2014 
    There is a Tide in the Affairs of MannKind: When Taken At the Flood, Will Lead to Fortune Aug 14 2014 

    More From Other Websites
    Harwood Feffer LLP Announces Investigation of MannKind Corporation Feb 12 2016
    MANNKIND CORP Financials Feb 12 2016
    SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of... Feb 11 2016
    Morgan Stanley is Wrong: This Biotech is Ready to Explode Higher Feb 11 2016
    IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against MannKind... Feb 10 2016
    INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of MannKind Corp. of Class Action Lawsuit... Feb 10 2016
    Major Biotech Short Interest Continues to Be Mixed Feb 10 2016
    The 6 Most Shorted Nasdaq Stocks: Short Sellers in Retreat Feb 10 2016
    [$$] How a Sanofi Diabetes Bet Went Wrong Feb 10 2016
    IMPORTANT SHAREHOLDER NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit against... Feb 09 2016
    [$$] Sanofi Is Forced to End Latest Diabetes Effort Feb 09 2016
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Feb 08 2016
    Hagens Berman Reminds MannKind Corp. (NASDAQGM: MNKD) Investors of March 15, 2016 Lead Plaintiff... Feb 08 2016
    Biotechnology Stocks Technical Review -- MannKind, Array BioPharma, Arena Pharma, and Chimerix Feb 08 2016
    INVESTOR ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving MannKind... Feb 05 2016
    MannKind Fails Twitter Like It Does Afrezza Feb 04 2016
    These Biotech Companies are Helping Turn Around the Sector for Major Gains in 2016 Feb 03 2016
    Will MannKind (MNKD) Continue to Surge Higher? Feb 03 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)